Govt starts pricing talks on drugs, med devices with pharma bodies
Several controversial issues, as per the industry sources, including pricing of patented drugs, rationalisation of trade margins, adopting a uniform code of practices and patient support programmes were discussed. Officials from the Department of Pharmaceuticals and National Pharmaceutical Pricing Authority led the talks.
Source – ETHealth World
